KARGEN

Kargen Bioscience is a biotechnology company that integrates artificial intelligence with functional genomics to advance precision medicine. The company's proprietary K-Map platform utilizes high-throughput screening and deep learning to systematically evaluate the functional impact of genetic variants at scale. This technology enables the identification of novel drug targets and the development of optimized small molecule therapies for oncology and rare genetic disorders. By bridging the gap between genomic data and therapeutic intervention, Kargen aims to streamline the drug discovery process and improve patient outcomes in targeted therapy.